Format

Send to

Choose Destination
ACS Chem Biol. 2016 Nov 18;11(11):3007-3023. Epub 2016 Sep 13.

Understanding Cytotoxicity and Cytostaticity in a High-Throughput Screening Collection.

Author information

1
Centre for Molecular Informatics, Department of Chemistry, University of Cambridge , Cambridge, United Kingdom.
2
Discovery Sciences, AstraZeneca R&D , Waltham, United States.
3
Discovery Sciences, AstraZeneca R&D , Cambridge Science Park, Cambridge, United Kingdom.
4
Discovery Sciences, AstraZeneca R&D , Alderley Park, Macclesfield, United Kingdom.
5
Discovery Sciences, AstraZeneca R&D , Mölndal, Sweden.

Abstract

While mechanisms of cytotoxicity and cytostaticity have been studied extensively from the biological side, relatively little is currently understood regarding areas of chemical space leading to cytotoxicity and cytostasis in large compound collections. Predicting and rationalizing potential adverse mechanism-of-actions (MoAs) of small molecules is however crucial for screening library design, given the link of even low level cytotoxicity and adverse events observed in man. In this study, we analyzed results from a cell-based cytotoxicity screening cascade, comprising 296 970 nontoxic, 5784 cytotoxic and cytostatic, and 2327 cytostatic-only compounds evaluated on the THP-1 cell-line. We employed an in silico MoA analysis protocol, utilizing 9.5 million active and 602 million inactive bioactivity points to generate target predictions, annotate predicted targets with pathways, and calculate enrichment metrics to highlight targets and pathways. Predictions identify known mechanisms for the top ranking targets and pathways for both phenotypes after review and indicate that while processes involved in cytotoxicity versus cytostaticity seem to overlap, differences between both phenotypes seem to exist to some extent. Cytotoxic predictions highlight many kinases, including the potentially novel cytotoxicity-related target STK32C, while cytostatic predictions outline targets linked with response to DNA damage, metabolism, and cytoskeletal machinery. Fragment analysis was also employed to generate a library of toxicophores to improve general understanding of the chemical features driving toxicity. We highlight substructures with potential kinase-dependent and kinase-independent mechanisms of toxicity. We also trained a cytotoxic classification model on proprietary and public compound readouts, and prospectively validated these on 988 novel compounds comprising difficult and trivial testing instances, to establish the applicability domain of models. The proprietary model performed with precision and recall scores of 77.9% and 83.8%, respectively. The MoA results and top ranking substructures with accompanying MoA predictions are available as a platform to assess screening collections.

PMID:
27571164
DOI:
10.1021/acschembio.6b00538
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center